ABCG2 and cancer: Regarding the wide range of chemotherapy drugs that are substrates of BCRP, it appears that finding an effective drug strategy to overcome drug resistance with a selectivity property of cancer cells to reduce drug resistance to chemotherapy agents can be a hope for more successful treatment of the patients, which requires the exploration of other signaling pathways affecting MTX drug resistance and BCRP transporter.